Abstract

Mutation signatures represent unique sequence footprints of somatic mutations resulting from specific DNA mutagenic and repair processes. However, their causal associations and the potential utility for genome research remain largely unknown. In this study, we performed PanCancer-scale correlative analyses to identify the genomic features associated with tumor mutation burdens (TMB) and individual mutation signatures. We observed that TMB was correlated with tumor purity, ploidy, and the level of aneuploidy, as well as with the expression of cell proliferation-related genes representing genomic covariates in evaluating TMB. Correlative analyses of mutation signature levels with genes belonging to specific DNA damage-repair processes revealed that deficiencies of NHEJ1 and ALKBH3 may contribute to mutations in the settings of APOBEC cytidine deaminase activation and DNA mismatch repair deficiency, respectively. We further employed a strategy to identify feature-driven, de novo mutation signatures and demonstrated that mutation signatures can be reconstructed using known causal features. Using the strategy, we further identified tumor hypoxia-related mutation signatures similar to the APOBEC-related mutation signatures, suggesting that APOBEC activity mediates hypoxia-related mutational consequences in cancer genomes. Our study advances the mechanistic insights into the TMB and signature-based DNA mutagenic and repair processes in cancer genomes. We also propose that feature-driven mutation signature analysis can further extend the categories of cancer-relevant mutation signatures and their causal relationships.

Highlights

  • Recent advances in genomic sequencing technologies have yielded a huge catalog of somatic mutations in cancer genomes across diverse tumor types [1]

  • We proposed a feature-driven mutation signature discovery method to identify de novo mutation signatures as differential trinucleotide frequencies based on tumor features of interests, such as homologous recombination (HR) deficiency or tumor hypoxia

  • Genomic features associated with tumor mutation burden (TMB) across cancer genomes To identify potential genomic covariates of TMB, we performed a PanCancer-scale correlative analysis with systematic genomic features, such as tumor purity and ploidy for 9,857 the PanCancer-scale Cancer Genome Atlas (TCGA) cases

Read more

Summary

Introduction

Recent advances in genomic sequencing technologies have yielded a huge catalog of somatic mutations in cancer genomes across diverse tumor types [1]. Jeong HY et al Mutation signatures and TMB of cancer genomes mor types [7], with varying causal mechanisms that lead to hypermutation and mutator phenotypes [8]. To advance our understanding on the heterogeneity of TMB and its clinical relevance, it is essential to assess the roles of various exogenous and endogenous mutagenic agents and DNA repair-replication processes [9], as well as their relationship with genomic features. Signature-level mutation analysis enables the molecular dissection of TMB according to the distinct origins of the mutations because mutation signatures are often associated with causal genetic mechanisms or genes corresponding to endogenous mutagens and DNA repair-replication processes. Deregulation of DNA repair or the proofreading polymerase genes of BRCA - [15] and POLE-deficient genomes [16] leads to mutations consistent with Sig.#3 and Sig.#10, respectively [10]. The genetic mechanisms and potential gene markers for the majority of mutation signatures are still largely unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call